Lee Patterson appointed as Metrion Biosciences CEO

Metrion Biosciences has appointed Lee Patterson as its new CEO, effective 2 December.

An experienced life sciences and CRO executive, Lee will guide the ion channel screening company as it develops an ambitious growth strategy, enhancing its specialist services and expanding further in key global markets.

Lee succeeds Dr Andrew Southan, who has stepped down after five years in the CEO role.

Keith McCullagh, Metrion Biosciences’ chairman, said: “On behalf of the board and management team, I would like to thank Andy Southan for his dedicated leadership over the last five years, in particular establishing Metrion’s reputation as a high-quality, specialist CRO and a leading centre of expertise in ion channel biology.

“At the same time, I am delighted to welcome Lee Patterson to the company. We look forward to working with him to continue Metrion’s growth as a specialist CRO serving global markets.”

Lee Patterson said: “I am excited to join this talented team and look forward to working with them to enhance and expand our specialised services to meet the needs of our clients worldwide.”